Factor Xa inhibitor

Related by string. factor Xa inhibitor * factoring . factored . factors . Factors : CERTAIN MARKET FACTORS SUCH . Risk Factors section . heading Risk Factors . X Factor Cher Lloyd / XA . xa . xAD . XAS : Infor ERP XA . Scion xA . Infor XA . XA Spartan 3A / Inhibitor . Inhibitors . inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . ACE inhibitors * *

Related by context. Frequent words. (Click for all words.) 71 angiogenesis inhibitor 70 oral anticoagulant 70 Laquinimod 70 BAY #-# 69 Herceptin trastuzumab 68 Panzem R 68 Naproxcinod 68 Mipomersen 67 direct thrombin inhibitor 67 pertuzumab 67 filgrastim 67 dalbavancin 67 HuMax CD# 67 betrixaban 67 Targretin 67 Desmoteplase 67 pegylated 67 Erlotinib 67 RSD# 66 pitavastatin 66 Rivaroxaban 66 atacicept 66 Arixtra 66 antithrombotic 66 Vilazodone 66 daptomycin 66 Oxaliplatin 66 PEGylated 66 liposomal formulation 66 goserelin 66 eltrombopag 66 Avastin bevacizumab 66 INTEGRILIN 66 SCH # 66 Cyclosporine 65 Amrubicin 65 Icatibant 65 Carfilzomib 65 elotuzumab 65 amphotericin B 65 mTOR inhibitor 65 Rebif ® 65 Traficet EN 65 cangrelor 65 anticancer compound 65 glatiramer acetate 65 Emend 65 Irinotecan 65 anti thrombotic 65 Nexavar ® 65 ISTODAX 65 Combination therapy 65 Natalizumab 65 Pirfenidone 65 proteasome inhibitors 65 bevacizumab Avastin 65 Promacta 65 Torisel 65 octreotide 65 Octreotide 65 methylnaltrexone 64 Apixaban 64 antifungal agent 64 GLPG# 64 diabetic neuropathic pain 64 zileuton 64 fumarate 64 Chrysalin 64 antiplatelet 64 deforolimus 64 chemotherapeutic drug 64 NVA# 64 CA4P 64 liprotamase 64 tocilizumab 64 romidepsin 64 antiangiogenic 64 eniluracil 64 muraglitazar 64 tipranavir 64 Ventavis 64 R sorafenib tablets 64 Vandetanib 64 Neurodex 64 oxybutynin 64 NOXAFIL 64 temsirolimus 63 neuroprotective properties 63 Everolimus 63 nitric oxide donating 63 Linaclotide 63 Fidaxomicin 63 Sym# 63 Elesclomol 63 KNS # 63 vasodilators 63 Hycamtin 63 Treanda 63 intravenously administered 63 tezampanel 63 daclizumab

Back to home page